OverviewChartProfileKey statisticsFinancialsNews
Derivatives
TraderScreen

FRESENIUS SE+CO.KGAA O.N./  DE0005785604  /

Frankfurt
2024-04-25  5:08:18 PM Chg. -0.0500 Volume Bid6:35:38 PM Ask6:35:38 PM Market Capitalization Dividend Y. P/E Ratio
27.2800EUR -0.18% 3,660
Turnover: 100,147.2000		 27.0900Bid Size: 466 27.2200Ask Size: 463 15.37 bill.EUR - -
GlobeNewswire 04-23 Transferring Biomedical Research to Patients Faster: ForTra gGmbH Announces Positive Funding Track R...
TeleTrader 01-15 Europe closes lower after data
GlobeNewswire 01-04 Sigyn Therapeutics Releases Letter to Shareholders
TeleTrader 2023-11-17 Europe opens higher ahead of CPI figures
GlobeNewswire 2023-11-09 CytoSorbents Reports Third Quarter 2023 Financial and Operational Results
TeleTrader 2023-11-02 Europe opens higher ahead of BoE decision
GlobeNewswire 2023-09-04 CIO Leadership: Generative AI and Visionary Leadership in the Enterprise Will Power the Discussion a...
GlobeNewswire 2023-08-31 CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil
TeleTrader 2023-07-11 Europe opens mostly higher with data, NATO in focus
TeleTrader 2022-12-23 Europe closes mixed ahead of Christmas
TeleTrader 2022-10-31 Europe closes mostly higher, inflation hits new record
GlobeNewswire 2022-02-25 Kapruvia® receives positive CHMP opinion for the treatment of moderate-to-severe pruritus in hemodia...
TeleTrader 2022-02-22 Europe closes mostly lower amid Ukraine worries
GlobeNewswire 2022-02-03 RAYALDEE® Launched in Germany by OPKO Health’s Licensee, VFMCRP
TeleTrader 2022-01-17 Europe opens higher amid the Forum, COVID data
GlobeNewswire 2022-01-05 Oculis appoints Mr. Webb Ding as Global Chief Operating Officer and General Manager (China)
GlobeNewswire 2021-12-31 CIO Leadership: HMG Strategy, the World’s #1 Executive Leadership Network, Looks Ahead to its 15th Y...
GlobeNewswire 2021-12-09 Angion and Vifor Pharma Report Topline Results from Phase 2 GUARD Trial of ANG-3777 in Cardiac Surge...
GlobeNewswire 2021-11-22 Vifor Pharma to acquire Sanifit to further strengthen late-stage pipeline in nephrology
GlobeNewswire 2021-11-22 Vifor Pharma to acquire Sanifit to further strengthen late-stage pipeline in nephrology
GlobeNewswire 2021-11-12 Humacyte Reports Third Quarter 2021 Financial Results and Provides Business Highlights
GlobeNewswire 2021-11-08 Cara Therapeutics Reports Third Quarter 2021 Financial Results
GlobeNewswire 2021-10-27 CIO Leadership: Exemplifying Authentic Leadership and Leveraging Personal Branding to Act as a Globa...
GlobeNewswire 2021-10-26 Angion and Vifor Pharma Report Topline Results from Phase 3 Trial of ANG-3777 in Kidney Transplant P...
GlobeNewswire 2021-09-15 Travere Therapeutics and Vifor Pharma Announce Licensing Agreement for the Commercialization of Spar...